588 related articles for article (PubMed ID: 17727369)
1. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
Xiao T; Li B; Wang YK; He CD; Chen HD
J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
[TBL] [Abstract][Full Text] [Related]
2. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
3. Case of localized bullous pemphigoid with unique clinical manifestations in the lower legs.
Kohroh K; Suga Y; Mizuno Y; Ishii N; Hashimoto T; Ikeda S
J Dermatol; 2007 Jul; 34(7):482-5. PubMed ID: 17584328
[TBL] [Abstract][Full Text] [Related]
4. Childhood bullous pemphigoid: clinical and immunological findings in a series of 4 cases.
Martinez-De Pablo MI; González-Enseñat MA; Vicente A; Gilaberte M; Mascaró JM
Arch Dermatol; 2007 Feb; 143(2):215-20. PubMed ID: 17310001
[TBL] [Abstract][Full Text] [Related]
5. The predominance of IgG4 in prodromal bullous pemphigoid.
Lamb PM; Patton T; Deng JS
Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
7. Postvaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin.
Ister M; Pouessel G; Ythier H; Catteau B; Carpentier O
Pediatr Dermatol; 2014; 31(4):e94-5. PubMed ID: 24916151
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.
Mulyowa GK; Jaeger G; Kabakyenga J; Bröcker EB; Zillikens D; Schmidt E
Int J Dermatol; 2006 Sep; 45(9):1047-52. PubMed ID: 16961507
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
10. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG.
Wawrzycki B; Krasowska D; Pietrzak A; Szumilo J; Blazowski L; Pietraszek-Mamcarz J; Lotti T
Dermatol Ther; 2018 Sep; 31(5):e12635. PubMed ID: 30216603
[TBL] [Abstract][Full Text] [Related]
11. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?
Wilczek A; Sticherling M
Int J Dermatol; 2006 Nov; 45(11):1353-7. PubMed ID: 17076725
[TBL] [Abstract][Full Text] [Related]
12. An infant with bullous pemphigoid.
Santos AL; Mota AV; Ramon J; Lopes JM; Azevedo F
Dermatol Online J; 2007 Jul; 13(3):17. PubMed ID: 18328211
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test.
Barnadas MA; Gilaberte M; Pujol R; Agustí M; Gelpí C; Alomar A
Int J Dermatol; 2006 Sep; 45(9):1089-92. PubMed ID: 16961518
[TBL] [Abstract][Full Text] [Related]
14. A case of generalized pustular psoriasis followed by bullous disease: an atypical case of bullous pemphigoid or a novel bullous disease?
Saeki H; Hayashi N; Komine M; Soma Y; Shimada S; Watanabe K; Hashimoto T
Br J Dermatol; 1996 Jan; 134(1):152-5. PubMed ID: 8745904
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of anti-p200 pemphigoid.
Rose C; Weyers W; Denisjuk N; Hillen U; Zillikens D; Shimanovich I
Am J Dermatopathol; 2007 Apr; 29(2):119-24. PubMed ID: 17414431
[TBL] [Abstract][Full Text] [Related]
16. [Erythroderma with immunoglobulin deposits along the basal membrane. Pemphigoid erythroderma?].
Scrivener Y; Cribier B; Le Coz C; Boehm N; Jelen G; Heid E; Grosshans E
Ann Dermatol Venereol; 1998 Jan; 125(1):13-7. PubMed ID: 9747199
[TBL] [Abstract][Full Text] [Related]
17. A vesicular variant of bullous pemphigoid with autoantibodies against unidentified 205- and 150-kDa proteins at the basement membrane zone.
Satoh S; Seishima M; Izumi T; Ito A; Kamiya H; Kitajima Y
Br J Dermatol; 1997 Nov; 137(5):768-73. PubMed ID: 9415239
[TBL] [Abstract][Full Text] [Related]
18. Bullous pemphigoid.
Korman NJ
Dermatol Clin; 1993 Jul; 11(3):483-98. PubMed ID: 8365034
[TBL] [Abstract][Full Text] [Related]
19. Serum from normal elderly individuals contains anti-basement membrane zone antibodies.
Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y
Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031
[TBL] [Abstract][Full Text] [Related]
20. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
